Downloads
Communities | White Papers
Swoop
Empowering Patients: How Pharma Ads Drive Better Health Outcomes
Survey reveals 67% of patients with chronic conditions took an action after seeing treatment advertising
Communities | Patient Insights
Swoop
Experiences With Ruxolitinib Cream in Patients’ Own Words: A Social Listening Analysis
Objective To understand patient experiences in their own words, including the benefits and challenges of using ruxolitinib cream. Introductions Vitiligo is a chronic, autoimmune skin disease that results in patches of skin depigmentation. MyVitiligoTeam members organically share their experiences living with and managing vitiligo with one another. This study examines recent treatment conversations centered on […]
Communities | Patient Insights
Swoop
Living With Secondary Progressive Multiple Sclerosis
Understanding the quality-of-life impact of SPMS along with patient desired outcomes can help neurologists develop the most effective approach to treating patients for whom MS is advancing.
Privacy | Best Practices
Swoop
Swoop Answers Your Data Privacy Questions
As states tighten privacy regulations, partnering with a compliant data provider isn’t just a best practice. It’s a necessity.
Swoop Web Solutions | White Papers
Swoop
From Whispers to Wisdom: AI’s Role in Demystifying IUD Conversations
How Swoop Web Solutions provide patients and providers round-the-clock, accurate information.
Conversational AI | Infographics
Swoop
Conversational AI in Pharma: Avoid the Pitfalls of Building In-House
In today’s digital world, patients and healthcare providers (HCPs) expect instant access to information. With 82% of consumers preferring conversational AI over waiting for a customer service representative, the question isn’t if pharmaceutical brands should implement a virtual agent on their website, but how.
Communities | Patient Insights
Swoop
Understanding the Debilitating Nature of Narcolepsy in Patients’ Own Words: A Social Listening Analysis
Background Narcolepsy is a rare, chronic hypersomnolence disorder characterized by debilitating symptoms, including excessive daytime sleepiness (EDS), cataplexy, and disrupted nighttime sleep. Symptoms most typically appear during adolescence2; however, previous reports suggest that diagnosis can be complicated by lack of symptom recognition or misdiagnoses and may be delayed by >10 years. Real-world information and experiences […]
Communities | Patient Insights
Swoop
Matching Anti-Seizure Medications’ Formulations to Patients: Why It Matters
Objective To understand the healthcare provider (HCP) and parent/caregiver dialogue regarding swallowing challenges of anti-seizure medications (ASMs) in children with epilepsy. Background Challenges swallowing oral medications among children have been shown to affect adherence to treatment. This survey is of critical importance for the practicing neurologist, as it addresses issues related to medication formulation availability […]
Communities | Patient Insights
Swoop
Patient Reported Attitudes Towards Multiple Sclerosis Treatment
Background Obstacles exist for getting patients on disease modifying treatments (DMTs) to slow progression. Understanding patient concerns can enable neurologists to help patients overcome barriers. Objective Research was undertaken to better understand awareness, usage, and attitudes towards DMTs.
Predictive Audiences | Case Studies
Swoop
A Leading Pharmaceutical Brand Increased Adherence 29% YoY with Swoop’s Patented Predictive Non-Adherence Audiences
With an increased incidence in substance use disorders (SUDs), a MAT therapy wanted to increase adherence within its patient population to drive positive patient outcomes. Leveraging Swoop’s patented predictive technology, the brand was able to accurately identify patients most likely to become non-adherent and activate them programmatically across premium inventory.